Vasculitic neuropathy induced by pembrolizumab

Ann Oncol. 2017 Feb 1;28(2):433-434. doi: 10.1093/annonc/mdw613.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use
  • Female
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Melanoma / drug therapy
  • Melanoma / pathology
  • Middle Aged
  • Peripheral Nervous System Diseases / chemically induced*
  • Vasculitis / chemically induced*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab